The EPIBASE brand, founded in 2002 (Belgium), from 167 sister brands and 2617 competing brands. The EPIBASE brand is owned by LONZA GRP, a company listed in Zurich. The International Securities Identification Number (ISIN) of LONZA GRP is CH0013841017. EPIBASE belongs to the Medical Diagnostics & Research business sector.

EPIBASE is a brand of LONZA GRP (LONN) Share price

Share price and profitability of the share LONZA GRP (EPIBASE)

Buy LONZA GRP share with

(0% commission and fractional shares)

Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested CHF 506.80

Portfolio valuation
LONZA GRP (EPIBASE) over 5 years* CHF 828.16

Stock market history LONZA GRP (EPIBASE)

Market prices -> Notoriety

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
LONZA GRP

See more brands of LONZA GRP

Rival brands
EPIBASE

Diagnostic International Distribution

Oxford Immunotec

Nexcelom Bioscience

OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking